ALKS Q2 2017 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$219M+12.1% YoY

Gross Profit

$179M81.8% margin

Operating Income

-$45M-20.3% margin

Net Income

-$43M-19.6% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+14.1%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$34M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$529M

Stockholders' Equity

$1.2B

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$219M	$195M	+12.1%
Gross Profit	$179M	$161M	+11.1%
Operating Income	-$45M	-$47M	+5.5%
Net Income	-$43M	-$47M	+8.9%